Correction to: MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway (Cancer Biology & Therapy, (2014), 15, 6, (806-814), 10.4161/cbt.28584);MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway

Cancer Biology and Therapy

Volumn 15, Issue 6, 2014, Pages 806-814

  Wu, Xiang Song ^a,b   Wang, Xu An ^a,b   Wu, Wen Guang ^a,b   Hu, Yun Ping ^a,b   Li, Mao Lan ^a,b   Ding, Qian ^a,b   Weng, Hao ^a,b   Shu, Yi Jun ^a,b   Liu, Tian Yu ^a,b   Jiang, Lin ^a,b   Cao, Yang ^a,b   Bao, Run Fa ^a,b   Mu, Jia Sheng ^a,b   Tan, Zhu Jun ^a,b   Tao, Feng ^c   Liu, Ying Bin ^a,b  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shaoxing People's Hospital   (China)

Author keywords

ERK; Gallbladder carcinoma; lncRNA; MALAT1; MAPK; Metastasis; Proliferation

Indexed keywords

LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL FUNCTIONS; CANCER PROGNOSIS; CELL CYCLE; CELL PROLIFERATION; CHOLECYSTECTOMY; CLINICAL ARTICLE; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER CELL LINE; GALLBLADDER CARCINOMA; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ADENOCARCINOMA; CELL MOTION; GALLBLADDER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECONDARY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GALLBLADDER NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; RNA, LONG NONCODING;

EID: 84901715681     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2024.2299054     Document Type: Erratum

References (36)

1. Coburn NG, Cleary SP, Tan JC, Law CH. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg 2008; 207:371-82; PMID:18722943; http://dx.doi.org/10.1016/j.jamcollsurg.2008.02.031
2. Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, Cheng Y, Cheng DQ, Weng WH, Wu XS, Fei XZ, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 2009; 281:71-81; PMID:19299076; http://dx.doi.org/10.1016/j.canlet.2009.02.020
3. Liu YB, He XW, Wang JW, Li JT, Li KQ, Liu FB, Xue JF, Zhu JH, Li B, Peng SY. [Establishment of liver metastasis model of human gallbladder cancer and isolation of the subpopulation with high metastatic potential]. Zhonghua Yi Xue Za Zhi 2006; 86:2117-21; PMID:17064616
4. Quan Z, Gu J, Dong P, Lu J, Wu X, Wu W, Fei X, Li S, Wang Y, Wang J, et al. Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells. Cancer Lett 2010; 295:252-9; PMID:20359814; http://dx.doi.org/10.1016/j.canlet.2010.03.008
5. Dong P, Zhang Y, Gu J, Wu W, Li M, Yang J, Zhang L, Lu J, Mu J, Chen L, et al. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. J Ethnopharmacol 2011; 137:1373-80; PMID:21855619; http://dx.doi.org/10.1016/j.jep.2011.08.005
6. Dong P, He XW, Gu J, Wu WG, Li ML, Yang JH, Zhang L, Ding QC, Lu JH, Mu JS, et al. Vimentin significantly promoted gallbladder carcinoma metastasis. Chin Med J (Engl) 2011; 124:4236-44; PMID:22340393
7. Zhang Z, Wang X, Wu W, Wang J, Wang Y, Wu X, Fei X, Li S, Zhang J, Dong P, et al. Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytother Res 2012; 26:932-7; PMID:22162124; http://dx.doi.org/10.1002/ptr.3657
8. Tan Z, Li M, Wu W, Zhang L, Ding Q, Wu X, Mu J, Liu Y. NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells. Mol Cell Biochem 2012; 369:27-33; PMID:22733362; http://dx.doi.org/10.1007/s11010- 012-1365-0
9. Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, Bao RF, Shu YJ, Ding QC, et al. Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder Carcinoma. Ann Surg Oncol 2013; (Forthcoming); PMID:24081806
10. Batra Y, Pal S, Dutta U, Desai P, Garg PK, Makharia G, Ahuja V, Pande GK, Sahni P, Chattopadhyay TK, et al. Gallbladder cancer in India: a dismal picture. J Gastroenterol Hepatol 2005; 20:309-14; PMID:15683437; http://dx.doi.org/10.1111/j.1440-1746.2005.03576.x
11. Bartlett DL, Fong Y, Fortner JG, Brennan MF, Blumgart LH. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 1996; 224:639-46; PMID:8916879; http://dx.doi.org/10.1097/ 00000658-199611000-00008
12. Butte JM, Matsuo K, Gönen M, D'Angelica MI, Waugh E, Allen PJ, Fong Y, DeMatteo RP, Blumgart L, Endo I, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg 2011; 212:50-61; PMID:21075015; http://dx.doi.org/10.1016/j.jamcollsurg.2010.09.009
13. Cziupka K, Partecke LI, Mirow L, Heidecke CD, Emde C, Hoffmann W, Siewert U, van den Berg N, von Bernstorff W, Stier A. Outcomes and prognostic factors in gallbladder cancer: a single-centre experience. Langenbecks Arch Surg 2012; 397:899-907; PMID:22454256; http://dx.doi.org/10.1007/s00423-012-0950-8
14. Bertone P, Stolc V, Royce TE, Rozowsky JS, Urban AE, Zhu X, Rinn JL, Tongprasit W, Samanta M, Weissman S, et al. Global identification of human transcribed sequences with genome tiling arrays. Science 2004; 306:2242-6; PMID:15539566; http://dx.doi.org/10.1126/science.1103388
15. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J, Hofacker IL, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007; 316:1484-8; PMID:17510325; http://dx.doi.org/10.1126/science.1138341
16. Chen LL, Carmichael GG. Long noncoding RNAs in mammalian cells: what, where, and why? Wiley Interdiscip Rev RNA 2010; 1:2-21; PMID:21956903
17. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012; 9:703-19; PMID:22664915; http://dx.doi.org/10. 4161/rna.20481
18. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003; 22:8031-41; PMID:12970751; http://dx.doi.org/10. 1038/sj.onc.1206928
19. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K, Akimitsu N. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010; 584:4575-80; PMID:20937273; http://dx.doi.org/10.1016/j.febslet.2010.10.008
20. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to- mesenchymal transition. Mol Biosyst 2012; 8:2289-94; PMID:22722759; http://dx.doi.org/10.1039/c2mb25070e
21. Hong SK, Yoon S, Moelling C, Arthan D, Park JI. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling. J Biol Chem 2009; 284:33006-18; PMID:19805545; http://dx.doi.org/10.1074/jbc.M109.012591
22. Xander P, Brito RR, Pérez EC, Pozzibon JM, de Souza CF, Pellegrino R, Bernardo V, Jasiulionis MG, Mariano M, Lopes JD. Crosstalk between B16 melanoma cells and B-1 lymphocytes induces global changes in tumor cell gene expression. Immunobiology 2013; 218:1293-303; PMID:23731774; http://dx.doi.org/10.1016/j.imbio.2013.04.017
23. Mercer TR, Dinger ME, Mattick JS. Long noncoding RNAs: insights into functions. Nat Rev Genet 2009; 10:155-9; PMID:19188922; http://dx.doi.org/10. 1038/nrg2521
24. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23:1494-504; PMID:19571179; http://dx.doi.org/10.1101/gad.1800909
25. Yuan SX, Yang F, Yang Y, Tao QF, Zhang J, Huang G, Yang Y, Wang RY, Yang S, Huo XS, et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrencefree survival after hepatectomy. Hepatology 2012; 56:2231-41; PMID:22706893; http://dx.doi.org/10. 1002/hep.25895
26. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 2007; 8:39-54; PMID:17270048; http://dx.doi.org/10.1186/1471-2164-8-39
27. Gutschner T, Baas M, Diederichs S. Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res 2011; 21:1944-54; PMID:21844124; http://dx.doi.org/10.1101/gr.122358. 111
28. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM, Zheng SS. Long noncoding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012; 29:1810-6; PMID:21678027; http://dx.doi.org/10.1007/s12032-011-0004-z
29. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010; 39:925-38; PMID:20797886; http://dx.doi.org/10.1016/j.molcel. 2010.08.011
30. Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al.; ENCODE Project Consortium; NISC Comparative Sequencing Program; Baylor College of Medicine Human Genome Sequencing Center; Washington University Genome Sequencing Center; Broad Institute; Children's Hospital Oakland Research Institute. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447:799-816; PMID:17571346; http://dx.doi.org/10.1038/nature05874
31. Yang L, Lin C, Liu W, Zhang J, Ohgi KA, Grinstein JD, Dorrestein PC, Rosenfeld MG. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 2011; 147:773-88; PMID:22078878; http://dx.doi.org/10.1016/j.cell.2011.08.054
32. De Luca A, Maiello MR, D'Alessio A, Pergameno M, Normanno N. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 2012; 16(Suppl 2):S17-27; PMID:22443084; http://dx.doi.org/10.1517/ 14728222.2011.639361
33. Min HJ, Lee Y, Zhao XF, Park YK, Lee MK, Lee JW, Kim S. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion. Cell Signal 2014; 26:398-408; PMID:23978400; http://dx.doi.org/10.1016/j.cellsig.2013.08.002
34. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013; 73:1180-9; PMID:23243023; http://dx.doi.org/10.1158/0008-5472.CAN-12-2850
35. Yiu GK, Kaunisto A, Chin YR, Toker A. NFAT promotes carcinoma invasive migration through glypican-6. Biochem J 2011; 440:157-66; PMID:21871017; http://dx.doi.org/10.1042/BJ20110530
36. Merabova N, Kaminski R, Krynska B, Amini S, Khalili K, Darbinyan A. JCV agnoprote-ininduced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons. J Cell Physiol 2012; 227:3119-27; PMID:22034072; http://dx.doi.org/10.1002/jcp.23065